Life sciences companies benefit from the ‘pharma carveout’ in Trump’s tariffs. But how long will it last?
The exemption may be short-lived if President Trump makes good on threats to use tariffs as leverage to bring drug production ...
Did Pfizer Delay Covid Vaccine Announcement Until After 2020 Election? Here’s What We Know.
Trump has claimed the company delayed an announcement for its vaccine until after the 2020 presidential election.
Fierce Pharma2d
As Trump's 'Liberation Day' tariffs seem to spare pharmaceuticals, threat of industry-specific duties and loopholes persists
With concerns mounting and speculation swirling, the particulars of President Donald Trump’s much-touted “Liberation Day” ...
Potential Stock Woe Ahead as Pfizer (PFE) Riles Donald Trump
Pfizer’s (PFE) stock has fallen ill since the COVID-19 pandemic waned, and it is still experiencing some aftereffects. The ...
Inside President Trump’s whirlwind decision to upend global trade
Not long after President Donald Trump’s inauguration, the administration’s economic staff went to work on a daunting task: ...
The Western Journal on MSN7d
Bombshell: Prosecutors Question Timing of Pfizer Announcement Released Just After 2020 Election
Just two days after Democrat Joe Biden was declared the winner of the 2020 presidential election, drugmaker Pfizer announced ...
Medical Marketing & Media1d
Trump’s sweeping new tariffs inject more uncertainty into pharma industry
Trump announced a 10% tariff on all U.S. trading partners, in addition to higher reciprocal tariffs on the EU and China. But ...
WSJ report of probe to have limited impact on Pfizer, says Citi
Citi analyst Geoff Meacham keeps a Neutral rating on Pfizer (PFE) with a $27 price target after the Wall Street Journal reported that U.S.